<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02510703</url>
  </required_header>
  <id_info>
    <org_study_id>09-085</org_study_id>
    <nct_id>NCT02510703</nct_id>
  </id_info>
  <brief_title>Assessment of Coronary Endothelial Function in Diabetic Patients With Acute Coronary Syndrome Using 15O-water Positron Emission Tomography</brief_title>
  <acronym>D-TEP</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Type 2 diabetes is associated with early and diffuse abnormalities of endothelial function,&#xD;
      especially in the coronary arteries, which are a factor of poor prognosis. Following acute&#xD;
      coronary syndrome, the endothelial function abnormalities usually persist for several weeks&#xD;
      before regressing. Their persistence 6-8 weeks after myocardial infarction is a poor&#xD;
      prognostic factor. Investigators assume that global abnormalities of endothelial function in&#xD;
      patients with diabetes may be additive with segmental abnormalities in revascularized&#xD;
      myocardium, and contribute to worsening the prognosis in these patients. Furthermore, there&#xD;
      is no published data showing any relationship between calcium score and endothelial function&#xD;
      abnormalities in these patients. The investigators seek a relationship between calcium score&#xD;
      and persistence of abnormalities of coronary endothelial function in these patients.&#xD;
&#xD;
      The main objective of this study was to compare coronary endothelial function by quantitative&#xD;
      method (TEP at 15O-H2O) in diabetic patients and nondiabetic following acute coronary&#xD;
      syndrome.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2011</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of quantitative variables coronary endothelial function in PET according to the presence or absence of type 2 diabetes in patients investigated with the waning of a first heart attack</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Type 2 diabetes group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Type 2 diabetes group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no diabetes</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>no diabetes</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coronary endothelial function measurements by quantitative method (TEP at 15O-H2O)</intervention_name>
    <arm_group_label>Type 2 diabetes group</arm_group_label>
    <arm_group_label>no diabetes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with a first myocardial infarction, type 2 diabetic or non-diabetic treated&#xD;
             by angioplasty in acute phase (TIMI 3)&#xD;
&#xD;
          -  Myocardial viability test before discharge&#xD;
&#xD;
          -  Age over 18 years&#xD;
&#xD;
          -  Informed Consent dated and signed by the patient&#xD;
&#xD;
          -  Written and spoken French&#xD;
&#xD;
          -  Beneficiary of social security insurance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hypertension&gt; 160/90 mmHg despite medical treatment&#xD;
&#xD;
          -  Lack of effective revascularization in acute phase of myocardial infarction (TIMI&#xD;
             grade &lt;3)&#xD;
&#xD;
          -  Significant three-vessel coronary artery disease (&gt; 70% stenosis in the other two&#xD;
             coronary arteries); occlusion of a coronary artery; schedule revascularization&#xD;
             (percutaneous or surgical); left main coronary artery stenosis&#xD;
&#xD;
          -  Previous history of myocardial infarction&#xD;
&#xD;
          -  Mechanical complication (mitral regurgitation, ventricular septal rupture, left&#xD;
             ventricular free wall rupture)&#xD;
&#xD;
          -  Heart failure&#xD;
&#xD;
          -  No myocardial viability test before discharge, for whatever reason&#xD;
&#xD;
          -  Type 1 diabetes&#xD;
&#xD;
          -  Pregnant and / or lactating&#xD;
&#xD;
          -  Age under 18 years or guardianship&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Service de Cardiologie</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain MANRIQUE, MD, PhD</last_name>
      <phone>02 31 06 31 06</phone>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <study_first_submitted>July 27, 2015</study_first_submitted>
  <study_first_submitted_qc>July 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2015</study_first_posted>
  <last_update_submitted>August 4, 2015</last_update_submitted>
  <last_update_submitted_qc>August 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

